{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:35:43Z","timestamp":1792046143335,"version":"4.4.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Agency of Jilin Province","award":["20150414020GH"],"award-info":[{"award-number":["20150414020GH"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0183622","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T13:40:24Z","timestamp":1504186824000},"page":"e0183622","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6032-1047","authenticated-orcid":true,"given":"Zan-Hui","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Hua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"S Vaughan","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"R Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"R Agarwal","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"9375","key":"ref4","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/S0140-6736(03)13726-9","article-title":"Chemotherapy for recurrent ovarian cancer","volume":"361","author":"SB Kaye","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/en.2011-2123","article-title":"Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy","volume":"153","author":"I Romero","year":"2012","journal-title":"Endocrinology"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0032-1304617","article-title":"Nerve growth factor stimulates cellular proliferation of human epithelial ovarian cancer","volume":"44","author":"U Urzua","year":"2012","journal-title":"Horm Metab Res"},{"issue":"6","key":"ref7","first-page":"391","article-title":"Matrix metalloproteinase-9: Many shades of function in cardiovascular disease","volume":"28","author":"A Yabluchanskiy","year":"2013","journal-title":"Physiology (Bethesda)"},{"issue":"31","key":"ref8","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"H Nagase","year":"1999","journal-title":"J Biol Chem"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s000180050320","article-title":"Structural properties of matrix metalloproteinases","volume":"55","author":"W Bode","year":"1999","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/10409238.2013.770819","article-title":"Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade","volume":"48","author":"J Vandooren","year":"2013","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"Pt 7","key":"ref11","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/awh489","article-title":"Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage","volume":"128","author":"J Wang","year":"2005","journal-title":"Brain"},{"issue":"19","key":"ref12","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1073\/pnas.0509808103","article-title":"Stat3 activation of NF-{kappa}B p100 processing involves CBP\/p300-mediated acetylation","volume":"103","author":"N Nadiminty","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5332","key":"ref13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"JE Darnell Jr.","year":"1997","journal-title":"Science"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"DE Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer\u2014new molecular targets come of age","volume":"4","author":"H Yu","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-4598-3-11","article-title":"Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines","volume":"3","author":"BE Barton","year":"2004","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13402-015-0251-7","article-title":"IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3&apos;-diindolylmethane in ovarian cancer cells","volume":"39","author":"M Zou","year":"2016","journal-title":"Cell Oncol (Dordr)"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"e88347","DOI":"10.1371\/journal.pone.0088347","article-title":"NF-kappaB inducing kinase, a central signaling component of the non-canonical pathway of NF-kappaB, contributes to ovarian cancer progression","volume":"9","author":"M Uno","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.placenta.2015.02.013","article-title":"STAT3 cooperates with the non-canonical NF-kappaB signaling to regulate pro-labor genes in the human placenta","volume":"36","author":"LJ Yu","year":"2015","journal-title":"Placenta"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bcp.2012.12.018","article-title":"Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1","volume":"85","author":"SC Gupta","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"LB Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer","volume":"38","author":"Y Guo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"ref23","first-page":"121","article-title":"Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer","volume":"39","author":"G Gastl","year":"2001","journal-title":"Methods Mol Med"},{"issue":"12","key":"ref24","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"P Lu","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"14","key":"ref25","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/j.1460-2075.1996.tb00734.x","article-title":"A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells","volume":"15","author":"K Nakajima","year":"1996","journal-title":"EMBO J"},{"issue":"3","key":"ref26","first-page":"547","article-title":"IL-6-inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like site binding protein(s)","volume":"12","author":"H Kojima","year":"1996","journal-title":"Oncogene"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00202068","article-title":"IL-6 cytokine family and signal transduction: a model of the cytokine system","volume":"74","author":"M Hibi","year":"1996","journal-title":"J Mol Med (Berl)"},{"issue":"23","key":"ref28","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1158\/0008-5472.CAN-05-0623","article-title":"Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine","volume":"65","author":"MB Nilsson","year":"2005","journal-title":"Cancer Res"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G","article-title":"Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway","volume":"42","author":"W Lou","year":"2000","journal-title":"Prostate"},{"issue":"391","key":"ref30","doi-asserted-by":"crossref","first-page":"ra85","DOI":"10.1126\/scisignal.aaa9806","article-title":"RelB\/p52-mediated NF-kappaB signaling alters histone acetylation to increase the abundance of corticotropin-releasing hormone in human placenta","volume":"8","author":"V Di Stefano","year":"2015","journal-title":"Sci Signal"},{"issue":"1","key":"ref31","first-page":"29","article-title":"New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression","volume":"1825","author":"B Bauvois","year":"2012","journal-title":"Biochim Biophys Acta"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0183622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T20:41:02Z","timestamp":1570048862000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0183622"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0183622","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]}}}